New Era for Rare Corneal Disorder

Healing of a neurotrophic corneal ulcer in a patient treated with cenegermin, viewed under white light(top row) and with fluorescein staining under cobalt-blue light (bottom row). (Bonini S, Lambiase A, Rama P, et al, for the Reparo Study Group. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125:1332-43. Permalink: https://doi.org. by the American Academy of Ophthalmology; reproduced under Creative Commons license CC BY-NC-ND 4.0)

For more information: http://www.ophthalmologytimes.com

Related Articles

Share on facebook
Share on whatsapp
Share on email